UPDATE: Achillion Has Received US Patent for ACH-3102, Structurally-Related NS5A Inhibitors
August 19, 2014 at 16:06 PM EDT
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) today announced that the U.S. Patent & Trademark Office has granted Achillion U.S. ...